Fiasp (Insulin Aspart (Vials)) and Inotuzumab ozogamicin
Determining the interaction of Fiasp (Insulin Aspart (Vials)) and Inotuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fiasp (Insulin Aspart (Vials))-Inotuzumab ozogamicin Intravenous
- Fiasp (Insulin Aspart (Vials))-Inova
- Fiasp (Insulin Aspart (Vials))-Inova 4/1 topical
- Fiasp (Insulin Aspart (Vials))-Inova 8/2 topical
- Fiasp (Insulin Aspart (Vials))-Inova ACT
- Fiasp (Insulin Aspart (Vials))-Inrebic
- Inotuzumab ozogamicin-Fiasp FlexTouch
- Inotuzumab ozogamicin-Fiasp Injection
- Inotuzumab ozogamicin-Fiber Lax
- Inotuzumab ozogamicin-Fiber Laxative
- Inotuzumab ozogamicin-FiberCon
- Inotuzumab ozogamicin-FiberGen